Insights from 2023 ASCO® Annual Meeting
B

ASCO® 2023 Insights: "Phase 3 LATIFY Study - Ceralasertib + Durvalumab vs. Docetaxel in Patients With Locally Advanced or Metastatic NSCLC That Progressed on or After Anti-PD-(L)1 & Platinum-Based Therapy"

By Insights from 2023 ASCO® Annual Meeting FEATURING Benjamin Besse
By Insights from 2023 ASCO® Annual Meeting FEATURING Benjamin Besse
135 views
July 9, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Related Content

AUTOPLAY
08:49

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

2.4K views
17:20

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

1.2K views
35:40

Year in Review: Lung Cancer

Balazs Halmos

2.6K views
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

799 views
18:47

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

6.4K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.1K views
17:05

Mediastinal Staging of Lung Cancer

MI&T Congressi

R. Trisolini

456 views
11:07

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

2.2K views
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

908 views
16:12

2024 Updates on the Fast-Changing NSCLC Landscape

Total Health

R. Osarogiagbon

444 views
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

491 views
26:38

New

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

241 views
14:49

Year in Review: Precision Medicine

Vivek Subbiah

941 views
13:19

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

E. Rodriguez

2.1K views
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

328 views
11:45

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in …

2024 ASCO® Annual Meeting Insights Hub

T. Mok

439 views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

406 views
09:37

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

Luis Raez

399 views
09:40

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

John Conibear

1.8K views
15:09

World Lung Cancer Day: Key Insights and Advances in Lung Cancer Trea…

Oncology Data Advisor

S. Kareff, B. Sandy, M. Vojnic

138 views